
RNS Hotlist November 30: Ananda, Ariana, Atlantic, Eco (Atlantic), Fulcrum, Good Life +, Greatland, Oncimmune, Serabi, StreaksAI
Yesterday Ananda Developments (AQUIS: ANA), the company whose ambition is to be a leading provider of cannabinoid-based medicines for the treatment of chronic, complex inflammatory